What is the share price of Jupiter Life Line Hospitals Ltd (JLHL) today?
The share price of JLHL as on 6th August 2026 is ₹319.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Jupiter Life Line Hospitals Ltd (JLHL) share?
The past returns of Jupiter Life Line Hospitals Ltd (JLHL) share are- Past 1 week: -1.83%
- Past 1 month: 9.49%
- Past 3 months: 27.93%
- Past 6 months: 27.52%
- Past 1 year: 15.15%
- Past 3 years: N/A%
- Past 5 years: 48.38%
What are the peers or stocks similar to Jupiter Life Line Hospitals Ltd (JLHL)?
The peers or stocks similar to Jupiter Life Line Hospitals Ltd (JLHL) include:What is the dividend yield % of Jupiter Life Line Hospitals Ltd (JLHL) share?
The current dividend yield of Jupiter Life Line Hospitals Ltd (JLHL) is 0.06.What is the market cap of Jupiter Life Line Hospitals Ltd (JLHL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jupiter Life Line Hospitals Ltd (JLHL) is ₹10620.06 Cr as of 6th August 2026.What is the 52 week high and low of Jupiter Life Line Hospitals Ltd (JLHL) share?
The 52-week high of Jupiter Life Line Hospitals Ltd (JLHL) is ₹340 and the 52-week low is ₹61.80.What is the PE and PB ratio of Jupiter Life Line Hospitals Ltd (JLHL) stock?
The P/E (price-to-earnings) ratio of Jupiter Life Line Hospitals Ltd (JLHL) is 54.74. The P/B (price-to-book) ratio is 6.88.Which sector does Jupiter Life Line Hospitals Ltd (JLHL) belong to?
Jupiter Life Line Hospitals Ltd (JLHL) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Jupiter Life Line Hospitals Ltd (JLHL) shares?
You can directly buy Jupiter Life Line Hospitals Ltd (JLHL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Jupiter Life Line Hospitals Ltd
JLHL Share Price
NSE₹319.250.71% (+2.25)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
JLHL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
JLHL Performance & Key Metrics
JLHL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 56.61 | 6.88 | 0.06% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.38 | 5.86 | 0.51% |
67%
Analysts have suggested that investors can buy this stock
from 6 analysts
Price Upside
Earnings Growth
Rev. Growth
JLHL Company Profile
Jupiter Life Line Hospitals Ltd operates multi-specialty hospitals in India, offering over 30 specialty treatments and promoting medical tourism.
APOLLOHOSP
PE Ratio
65.98
65.98
1Y Return
24.83%
24.83%
Buy Reco %
86.67
86.67
MAXHEALTH
PE Ratio
72.87
72.87
1Y Return
15.63%
15.63%
Buy Reco %
83.33
83.33
PE Ratio
189.12
189.12
1Y Return
41.41%
41.41%
Buy Reco %
100.00
100.00
FORTIS
PE Ratio
67.03
67.03
1Y Return
7.21%
7.21%
Buy Reco %
85.00
85.00
PE Ratio
47.98
47.98
1Y Return
6.58%
6.58%
Buy Reco %
85.71
85.71
JLHL Sentiment Analysis
JLHL Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
JLHL Stock Summary · May 2026
Strong FY26 operating performance alongside a measured, asset‑heavy growth plan was the dominant message, with revenue of INR 1,499.8 crore and an EBITDA margin of 22.9% anchoring the update. Management emphasised disciplined, quality‑led expansion—owning real estate to build full‑scale hubs in Mumbai and Pune—highlighting the newly commissioned Dombivli greenfield (on time, no cost overrun) and pipeline progress at Pune South, Mira Road and a flagship BKC quaternary project where land has been allotted and initial payment made. They stressed clinical, patient‑centric design and staged execution, while noting a near‑term drag as new hospitals ramp, accreditation and insurer empanelment require operational data and can take roughly 6–12 months. Funding is expected from strong operating cash flows and internal accruals supplemented by debt within a self‑imposed 3.0x EBITDA ceiling, having deployed about INR 500 crore this year and sitting net cash positive at the reporting date. Near term, management expects Dombivli to ramp toward breakeven in about two years and other units to mature over the next 1–3 years.
JLHL Stock Growth Drivers
JLHL Stock Growth Drivers
6Successful greenfield execution – Dombivli commissioned on time and on budget
The company completed and commissioned the Dombivli greenfield hospital ahead of its Q1 FY27 target,
Robust pipeline progress and flagship BKC development
Multiple greenfield projects are advancing on schedule: Pune South remains on track for a calendar
JLHL Stock Challenges
JLHL Stock Challenges
6Macroeconomic and capex cost pressure
Management flagged materially negative cost-side trends that could compress returns, specifically a depreciating rupee and
Near-term committed capital outflows and project funding uncertainty
The company has already committed cash to a major Mumbai land parcel (initial payment and
JLHL Forecast
JLHL Forecasts
Price
Revenue
Earnings
JLHL Share Price Forecast
JLHL Share Price Forecast
2026
Current
₹319.25
Baseline
Forecast for Aug 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹319.25
Baseline
Forecast for Aug 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
JLHL Company Revenue Forecast
JLHL Company Revenue Forecast
2026
Current
₹1.54
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹1.54
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
JLHL Stock EPS (Earnings Per Share) Forecast
JLHL Stock EPS (Earnings Per Share) Forecast
2026
Current
₹5.92
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹5.92
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
JLHL
JLHL
Income
Balance Sheet
Cash Flow
Quarterly Normal View
JLHL Income Statement
JLHL Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 301.72 | 295.50 | 342.46 | 340.02 | 343.54 | 365.77 | 404.90 | 374.50 | 398.50 | 421.57 | ||||||||||
Operating & Other expenses | 228.21 | 223.27 | 256.83 | 256.47 | 256.96 | 274.53 | 301.38 | 288.34 | 298.68 | 331.71 | ||||||||||
EBITDA | 73.51 | 72.23 | 85.63 | 83.55 | 86.58 | 91.24 | 103.52 | 86.16 | 99.82 | 89.86 | ||||||||||
| Depreciation/Amortization | 10.39 | 11.00 | 14.42 | 13.99 | 17.65 | 21.22 | 21.46 | 21.70 | 23.26 | 26.44 | ||||||||||
| PBIT | 63.12 | 61.23 | 71.21 | 69.56 | 68.93 | 70.02 | 82.06 | 64.46 | 76.56 | 63.42 | ||||||||||
| Interest & Other Items | 0.93 | 1.08 | 1.16 | 2.82 | 5.61 | 8.27 | 7.84 | 7.55 | 9.01 | 12.86 | ||||||||||
| PBT | 62.19 | 60.15 | 70.05 | 66.74 | 63.32 | 61.75 | 74.22 | 56.91 | 67.55 | 50.56 | ||||||||||
| Taxes & Other Items | 17.14 | 15.68 | 18.40 | 14.65 | 18.14 | 17.86 | 16.86 | 14.35 | 17.34 | 13.08 | ||||||||||
| Net Income | 45.05 | 44.47 | 51.65 | 52.09 | 45.18 | 43.89 | 57.36 | 42.56 | 50.21 | 37.48 | ||||||||||
| EPS | 1.30 | 1.36 | 1.58 | 1.59 | 1.37 | 1.34 | 1.75 | 1.30 | 1.53 | 1.14 |
JLHL Company Updates
FY 2027FY 2027
Investor Presentation
Jul 31PDF
JLHL Stock Peers
JLHL Past Performance & Peer Comparison
JLHL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Jupiter Life Line Hospitals Ltd | 54.74 | 6.88 | 0.06% |
| Apollo Hospitals Enterprise Limited | 65.98 | 12.84 | 0.22% |
| Max Healthcare Institute Limited | 72.87 | 9.78 | 0.19% |
| Aster DM Quality Care Limited | 189.12 | 20.10 | 0.20% |
JLHL Stock Price Comparison
Compare JLHL with any stock or ETFCompare JLHL with any stock or ETF
JLHL
JLHL Holdings
JLHL Shareholdings
JLHL Promoter Holdings Trend
JLHL Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
JLHL Institutional Holdings Trend
JLHL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
JLHL Shareholding Pattern
JLHL Shareholding Pattern
JLHL Shareholding History
JLHL Shareholding History
Foreign Institutions
Mutual Funds Invested in JLHL
Mutual Funds Invested in JLHL
No mutual funds holding trends are available
Top 5 Mutual Funds holding Jupiter Life Line Hospitals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 5.6151% | Percentage of the fund’s portfolio invested in the stock 2.52% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 7/76 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2041% | Percentage of the fund’s portfolio invested in the stock 2.56% | Change in the portfolio weight of the stock over the last 3 months -0.28% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 18/40 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.5143% | Percentage of the fund’s portfolio invested in the stock 0.78% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 32/100 (-1) |
Compare 3-month MF holding change on Screener
smallcases containing JLHL stock
smallcases containing JLHL stock
Looks like this stock is not in any smallcase yet.
JLHL Events
JLHL Events
JLHL Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
JLHL Dividend Trend
No dividend trend available
JLHL Upcoming Dividends
JLHL Upcoming Dividends
No upcoming dividends are available
JLHL Past Dividends
JLHL Past Dividends
Cash Dividend
Ex DateEx DateMay 22, 2026
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
May 22, 2026
Cash Dividend
Ex DateEx DateJul 4, 2025
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 4, 2025
Cash Dividend
Ex DateEx DateAug 2, 2024
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 2, 2024
JLHL Stock News & Opinions
JLHL Stock News & Opinions
Articles & Videos
Earnings
Earnings
Jupiter Life Line Hospitals Ltd consolidated sales up 5.97% on year in Q2FY2026Jupiter Life Line Hospitals Ltd share price gained 1.61% to Rs 332.3 after the company's net profit tumbled by 25.38% to Rs 37.51 crore, while revenue from operations improved marginally 5.97% to Rs 410.98 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 4.89 lakh crore, easing 5.94%. It has improved by 2.65% over last one week and soared by 20.97% in last one month while the market capitalization of Jupiter Life Line Hospitals Ltd has inched up 2.47% and 35.30% in the same period respectively. Profit before tax (PBT) of Jupiter Life Line Hospitals Ltd stood at Rs 50.55 crore in Q2 FY26, tumbling by 18.14% year-on-year, and plunging by 25.18% quarter-on-quarter. EBITDA came in at Rs 69 crore, gaining 4.70% YoY and retreating 14.17% sequentially. Total expenses rose by 11.25% to Rs 358.15 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 74.45 crore, registering a growth of 9.94% YoY. For the TTM ended FY26, revenue from operations rose 15.16% to Rs 1499.79 crore, while net profit saw a marginal increase of 0.23% to Rs 194.19 crore, compared to previous TTM. EBITDA surged by 30133% to Rs 300.89 crore, and PBT slipped by 0.09% to Rs 260.44 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 267.71 crore in FY26, as against Rs 253.3 crore in FY25. Jupiter Life Line Hospitals Ltd rallied 15.49% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 4.36% during the same period.
6 days agoCapital Market - Live
Corporate
Corporate
Jupiter Life Line Hospitals to table resultsJupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 31 July 2026.
1 week agoCapital Market - Live
Corporate
Corporate
Jupiter Life Line Hospitals to hold AGMJupiter Life Line Hospitals announced that the Annual General Meeting(AGM) of the company will be held on 17 July 2026.
1 month agoCapital Market - Live
Corporate
Corporate
Board of Jupiter Life Line Hospitals recommends interim dividendJupiter Life Line Hospitals announced that the Board of Directors of the Company at its meeting held on 15 May 2026, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.
2 months agoCapital Market - Live
Earnings
Earnings
Jupiter Life Line Hospitals consolidated net profit rises 11.13% in the March 2026 quarterNet profit of Jupiter Life Line Hospitals rose 11.13% to Rs 50.21 crore in the quarter ended March 2026 as against Rs 45.18 crore during the previous quarter ended March 2025. Sales rose 15.20% to Rs 387.84 crore in the quarter ended March 2026 as against Rs 336.66 crore during the previous quarter ended March 2025. For the full year,net profit rose 0.42% to Rs 194.01 crore in the year ended March 2026 as against Rs 193.20 crore during the previous year ended March 2025. Sales rose 15.16% to Rs 1499.79 crore in the year ended March 2026 as against Rs 1302.40 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales387.84336.66 15 1499.791302.40 15 OPM %22.9923.68 -22.8923.04 - PBDT89.3080.98 10 352.97317.76 11 PBT66.0563.32 4 265.33260.68 2 NP50.2145.18 11 194.01193.20 0 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Jupiter Life Line Hospitals announces board meeting dateJupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 15 May 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Jupiter Life Line Hospitals acquires land for proposed hospital at BKC, MumbaiJupiter Life Line Hospitals has received a letter from Mumbai Metropolitan Region Development Authority (MMRDA) conveying the acceptance of its tender for allotment of land on lease basis, for a period of 80 years. The said allotment pertains to land admeasuring an area of ~10,026.44 sqm on lease basis, for an amount of ~ Rs. 354 crore. The Land is situated at plot no. SF5 in GTxT-Block of Bandra Kurla Complex, Maharashtra. The aforesaid land is leased for setting up ~ 400 beds hospital subjected to various statutory and regulatory approvals.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Earnings
Jupiter Life Line Hospitals consolidated net profit declines 18.31% in the December 2025 quarterNet profit of Jupiter Life Line Hospitals declined 18.31% to Rs 42.55 crore in the quarter ended December 2025 as against Rs 52.09 crore during the previous quarter ended December 2024. Sales rose 9.78% to Rs 365.37 crore in the quarter ended December 2025 as against Rs 332.81 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales365.37332.81 10 OPM %22.8322.94 - PBDT85.0180.72 5 PBT63.3166.73 -5 NP42.5552.09 -18 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
Jupiter Life Line Hospitals to table resultsJupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Earnings
Jupiter Life Line Hospitals consolidated net profit rises 11.04% in the September 2025 quarterNet profit of Jupiter Life Line Hospitals rose 11.04% to Rs 57.35 crore in the quarter ended September 2025 as against Rs 51.65 crore during the previous quarter ended September 2024. Sales rose 17.48% to Rs 393.63 crore in the quarter ended September 2025 as against Rs 335.05 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales393.63335.05 17 OPM %23.4423.35 - PBDT95.6884.46 13 PBT74.2270.04 6 NP57.3551.65 11 Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 25.76%, vs industry avg of 16.34%
Over the last 5 years, market share increased from 1.16% to 1.67%